|

Bevacizumab Biosimilar Clinical Trials

3 actively recruiting trials across 1 location

Also known as: MVASI

Other2 trials

A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
Phase 1/2
HAIC Combined with Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03)
Phase 2

Orlando, Florida1 trial

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Orlando Health Cancer Institute ( Site 0065)

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.